Insights into european drug shortages: A survey of hospital pharmacists

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Kim, Pauwels ^a   Simoens, Steven ^a   Casteels, Minne ^a   Huys, Isabelle ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG SHORTAGE; EUROPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE CONCEPTS; HEALTH IMPACT ASSESSMENT; HUMAN; JOB STRESS; MEDICAL FEE; MEDICAL SERVICE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PHARMACIST; PHARMACIST ATTITUDE; QUALITY CONTROL; REVIEW; ECONOMICS; HOSPITAL PHARMACY; QUESTIONNAIRE; SUPPLY AND DISTRIBUTION;

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DRUG;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; EUROPE; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACY SERVICE, HOSPITAL; SURVEYS AND QUESTIONNAIRES;

EID: 84925252115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119322     Document Type: Review

References (37)

1. Cherici C, Frazier J, Feldman M, Gordon B, Petrykiw CA, et al. (2013) Navigating drug shortages in American health care. Available: https://www.premierinc.com/about/news/11-mar/drug-shortagewhite- paper-3-28-11.pdf. Accessed 20 June 2013
2. Mayer DK (2012) Anatomy of a drug shortage. Clin J Oncol Nurs 16: 107-108. Q24730M7546816W4 [pii];. doi: 10.1188/12.CJON.107-108 PMID: 22459517
3. Kaakeh R, Sweet BV, Reilly C, Bush C, DeLoach S, et al. (2011) Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm 68: 1811-1819. 68/19/1811 [pii];. doi: 10.2146/ajhp110210 PMID: 21930639
4. McBride A, Holle LM, Westendorf C, Sidebottom M, Griffith N, et al. (2013) National survey on the effect of oncology drug shortages on cancer care. Am J Health Syst Pharm 70: 609-617. 70/7/609 [pii];. doi: 10.2146/ajhp120563 PMID: 23515514
5. Rider AE, Templet DJ, Daley MJ, Shuman C, Smith LV (2013) Clinical dilemmas and a review of strategies to manage drug shortages. J Pharm Pract 26: 183-191. 0897190013482332 [pii];. doi: 10.1177/ 0897190013482332 PMID: 23553544
6. Alspach JG (2012) The drug shortage: What Critical Care Nurse readers report. Crit Care Nurse 32: 11-13. 32/5/11 [pii];. doi: 10.4037/ccn2012818 PMID: 23027786
7. American Hospital Association (2011) AHA survey on drug shortages. Available: Www.aha.org/ drugshortage. Accessed 21 June 2013
8. Institute for Safe Medication Practices (2010) Drug shortages: national survey reveal high level of frustration, low level of safety. Available: http://www.ismp.org/newsletters/acutecare/articles/20100923. asp. Accessed 28 August 2013
9. Gatesman ML, Smith TJ (2011) The shortage of essential chemotherapy drugs in the United States. N Engl J Med 365: 1653-1655. doi: 10.1056/NEJMp1109772 PMID: 22040130
10. Morrissey J (2012) The drug shortage. Hosp Health Netw 86: 46-50,PMID: 23330324
11. European Association of Pharmaceutical Full-line Wholesalers (2012) Medicine shortages in Europe and their impact on patients-A reflection paper. Available: http://girp.eu/files/7537b5f0-f4a6-11e2-80ffa960bb6c1e24/Medicines%20shortages%20reflection%20paper%20including%20exec.%20summary %20FINAL.pdf. Accessed 1 August 2013
12. Generics and Biosimilarrs Initiative (2011) Biosimilars and cancer drug shortages in Europe. Available: www.gabionline.net. Accessed 5 december 2013.
13. Generics and Biosimilarrs Initiative (2012) APPG reports on drug shortages and MHRA bans unlicensed stock trading. Available: www.gabionline.net. Accessed 5 december 2013.
14. Generics and Biosimilarrs Initiative (2012) UK drug shortages are far from being solved. Available: www.gabionline.net. Accessed 5 december 2013.
15. Generics and Biosimilarrs Initiative (2012) Drug shortage woes continue in the UK. Available: www.gabionline.net. Accessed 5 december 2013.
16. European Generic medicines Association (EGA) (2013) EGA Position paper: Tendering: Unsustainable mechanisms for EU Healthcare systems
17. European Association of Hospital Pharmacists (2013) Medicine shortages in European hospitals. Available: http://www.eahp.eu/practice-and-policy/medicines-shortages. Accessed 15 June 1013
18. Hall R, Bryson GL, Flowerdew G, Neilipovitz D, Grabowski-Comeau A, et al. (2013) Drug shortages in Canadian anesthesia: A national survey. Can J Anaesth 60: 539-551. doi: 10.1007/s12630-013-9920- z PMID: 23546924
19. ISPE (2013) Report on the ISPE drug shortages survey. Available: http://www.ispe.org/drugshortages- initiative. Accessed 5 June 2013
20. Ventola CL (2011) The drug shortage crisis in the United States: causes, impact, and management strategies. P T 36: 740-757. PMID: 22346307
21. United Nations Statistic Division (2013) Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. Available: http://unstats.un.org/ unsd/methods/m49/m49regin.htm. Accessed 11 November 2013
22. Gray A, Manasse HR (2012) Shortage of medicines: A complex global challange. Bulletin of the World Health Organization 154-154A
23. Capstick TG, Laycock D, Lipman MC (2011) Treatment interruptions and inconsistent supply of anti-tuberculosis drugs in the United Kingdom. Int J Tuberc Lung Dis 15: 754-760. doi: 10.5588/ijtld.10.0568 PMID: 21575294
24. Dal MF (2013) BCG shortage in Europe. Prev Med 57: 146. S0091-7435(13)00128-X [pii];. doi: 1016/j.ypmed.2013.04.019 PMID: 23648524
25. Tirelli U, Berretta M, Spina M, Michieli M, Lazzarini R (2012) Oncologic drug shortages also in Italy. Eur Rev Med Pharmacol Sci 16: 138-139. PMID: 23090831
26. IMS institute (2011) Drug Shortages: A Closer Look at Products, Suppliers and Volume Volatility. Available: http://www.imshealth.com/portal/site/ims/menuitem.edb2b81823f67dab41d84b903208c22a/?vgnextoid=a6fbcc0f68f73310VgnVCM100000ed152ca2RCRD Accessed 1 August 2013
27. Chabner BA (2011) Drug shortages-A critical challenge for the generic-drug market. N Engl J Med 365: 2147-2149. doi: 10.1056/NEJMp1112633 PMID: 22040167
28. Woodcock J, Wosinska M (2013) Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther 93: 170-176. clpt2012220 [pii];. doi: 10.1038/clpt.2012.220 PMID: 23337525
29. Birgli ag (2013) An Evaluation of Medicines Shortages in Europe with a more in-depth review of these in France,Greece, Poland, Spain, and the United Kingdom. Available: http://static.correofarmaceutico.com/docs/2013/10/21/evaluation.pdf. Accessed 2 April 2014
30. Dylst P, Vulto A, Simoens S (2011) Tendering for outpatient prescription pharmaceuticals: What can be learned from current practices in Europe? Health Policy 101: 146-152. S0168-8510(11)00050-9 [pii];. doi: 10.1016/j.healthpol.2011.03.004 PMID: 21511353
31. Official Journal Of the European Union (2004) Directive 2004/18/EC of the European parliament and of the council of 31 March 2004 on the coordination of procedures for the award of public works contracts, public supply contracts and public service contracts. Available: http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2004:134:0114:0240:en:PDF. Accessed: 1 August 2013
32. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP) (2013) Voorstel KNMP voor lage medicijnprijzen. Available: http://www.knmp.nl/nieuws/belangenbehartiging/ belangenbehartiging-2013/voorstel-knmp-voor-lage-medicijnprijzen. Accessed: 2 April 2014
33. Bart TN (2008) Parallel trade of pharmaceuticals: A review of legal, economic, and political aspects. Value Health 11: 996-1005. VHE339 [pii];. doi: 10.1111/j.1524-4733.2008.00339.x PMID: 18489506
34. Pharmaceutical Service Negotiating Committee (PSNC) (2013) Branded medicines shortages. Available: http://psnc.org.uk/dispensing-supply/supply-chain/branded-shortages/. Accessed 15 November 2013
35. IHS Healthcare and Pharma Blog (2012) Parallel exports lead to drug shortage problems in the heart of Europe. Available: http://healthcare.blogs.ihs.com/2012/10/09/parallel-exports-lead-to-drug-shortageproblems- in-the-heart-of-europe/. Accessed 5 december 2013
36. IHS Healthcare and Pharma Blog(2013) Drug shortages resulting from price decreases put patients at risk in Slovakia. Available: http://www.ihs.com/products/global-insight/industry-economic-report.aspx? id=1065983235. Accessed 5 december 2013
37. IHS Healthcare and Pharma Blog (2012) How cost-containment policies impact drug prices and reimbursement lists in CEE countries. Available: http://healthcare.blogs.ihs.com/2012/11/05/how-costcontainment-policies-impact-drug-prices-and-reimbursement-lists-in-cee-countries/